In multiple sclerosis, the expansion of classical (CD14++ CD16-) and nonclassical monocytes (CD14+ CD16 +) are sensitive markers of inflammation and could help to identify relapsing–remitting multiple sclerosis earlier14. The gene discussed is CD14; the disease is multiple sclerosis.